Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Apollomics
989 East Hillsdale Blvd, Suite 220
Foster City, CA 94588
Phone: 925-272-4090
https://www.apollomicsinc.com

Apollomics (fka CBT Pharmaceuticals) incubated by OrbiMed Asia at inception, is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies that harness the immune system and target specific molecular pathways to eradicate cancer. The company’s existing pipeline consists of six development-stage assets including three novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and three targeted therapies against uncontrolled growth signaling pathways.

Key Contact
Name
Dr. Sanjeev Redkar
Title
President
Funding Events

Date
Amount
Type
Investors
Valuation
08/29/16 $9,750,000 Series A OrbiMed Asia
undisclosed
01/09/19 $100,000,000 Series B CMB International
Junson Capital
K2VC
OrbiMed Asia
Pan-Lin Asset Management
undisclosed